Skip to main content
. 2017 Sep;12(9):1451–1457. doi: 10.4103/1673-5374.215257

Table 2.

Effects of BTXA treatment on assessed measures in patients with spastic strephenopodia and foot drop after stroke

graphic file with name NRR-12-1451-g004.jpg